Skip to content

Clinical trials

Schizophrenia trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Country / region: Switzerland Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20052
20072
20083
20101
20111
20131
20163
20184
20192
20201
20213
20232
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Unknown status6
Terminated4
Recruiting3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Bern7
Psychiatric University Hospital, Zurich5
AstraZeneca2
Janssen-Cilag International NV2
University of Zurich2
Bristol-Myers Squibb1
Christina Andreou1
Hospital Center Alpes-Isère1
Indrit Begue1
Institut et Haute Ecole de la Santé la Source1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia30
Psychotic Disorders13
Hallucinations3
Psychomotor Disorders3
Anhedonia2
Bipolar Disorder2
Lethargy2
Major Depressive Disorder2
Borderline Personality Disorder1
Cognitive Dysfunction1

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.